Laserfiche WebLink
b. Ensuring PDMPs incorporate available overdose/naloxone deployment data, <br />including the United States Department of Transportation's Emergency <br />Medical Technician overdose database. <br />7. Increase electronic prescribing to prevent diversion or forgery. <br />8. Educate Dispensers on appropriate opioid dispensing. <br />G. PREVENT MISUSE OF OPIOIDS <br />Support efforts to discourage or prevent misuse of opioids through evidence -based, evidence - <br />informed, or promising programs or strategies that may include, but are not limited to, the <br />following: <br />1. Corrective advertising or affirmative public education campaigns based on evidence. <br />2. Public education relating to drug disposal. <br />3. Drug take -back disposal or destruction programs. <br />4. Fund community anti -drug coalitions that engage in drug prevention efforts. <br />Support community coalitions in implementing evidence -informed prevention, such <br />as reduced social access and physical access, stigma reduction — including staffing, <br />educational campaigns, support for people in treatment or recovery, or training of <br />coalitions in evidence -informed implementation, including the Strategic Prevention <br />Framework developed by the U.S. Substance Abuse and Mental Health Services <br />Administration (SAMHSA). <br />6. Engage non -profits and faith -based communities as systems to support prevention. <br />7. Support evidence -informed school and community education programs and <br />campaigns for students, families, school employees, school athletic programs, parent - <br />teacher and student associations, and others. <br />8. School -based or youth -focused programs or strategies that have demonstrated <br />effectiveness in preventing drug misuse and seem likely to be effective in preventing <br />the uptake and use of opioids. <br />9. Support community -based education or intervention services for families, youth, and <br />adolescents at risk for OUD and any co-occurring SUD/MH conditions, co -usage, <br />and/or co -addiction. <br />10. Support evidence -informed programs or curricula to address mental health needs of <br />young people who may be at risk of misusing opioids or other drugs, including <br />emotional modulation and resilience skills. <br />11. Support greater access to mental health services and supports for young people, <br />including services and supports provided by school nurses or other school staff, to <br />E13 <br />